ArticleVaccines2022

Durability of Immune Response to ChAdOx1-nCoV-19 Vaccine in Solid Cancer Patients Undergoing Anticancer Treatment.

Passakorn Wanchaijiraboon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.